Rotavirus

• 

  Subject Areas on Research

  • A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. 
  • Burden of childhood rotavirus disease on health systems in the United States. 
  • Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis. 
  • Development of a monoclonal antibody specific for serotype 3 rotavirus strains. 
  • Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. 
  • Enteric viruses associated with HIV infection in Tanzanian children with chronic diarrhea. 
  • Estimating the Effectiveness of Rotavirus Vaccine Schedules. 
  • Glucose vs sucrose in oral rehydration solutions for infants and young children with rotavirus-associated diarrhea. 
  • Importance of vertebrate viruses for choosing hand antiseptics with virucidal efficacy. 
  • Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. 
  • Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. 
  • Molecular epidemiology of Rotavirus causing diarrhea among children less than five years of age visiting national level children hospitals, Nepal. 
  • Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule. 
  • Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution. 
  • Oral rehydration therapy for treatment of rotavirus diarrhoea in a rural treatment centre in Bangladesh. 
  • Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany. 
  • Rotavirus RNA polymerase requires the core shell protein to synthesize the double-stranded RNA genome. 
  • Rotavirus Vaccine and Intussusception Hospitalizations. 
  • Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. 
  • Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. 
  • Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis. 
  • Six-year retrospective surveillance of gastroenteritis viruses identified at ten electron microscopy centers in the United States and Canada. 
  • The actin cytoskeleton as a barrier to virus infection of polarized epithelial cells. 
  • The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis.